Rxivist logo

Author: Tal Patalon

Rankings

  • All-time downloads: 1,361,692 (rank: 10 )
  • Categories:
    • epidemiology: 127,026 (rank: 187 (tie) )
    • health policy: 1,257 (rank: 606 (tie) )
    • infectious diseases: 1,203,677 (rank: 1 )
    • public and global health: 9,585 (rank: 690 )

Downloads per author, site-wide

Preprints

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections

infectious diseases more details view paper
  • Downloaded 992,858 times
  • Download rankings, all-time:
    • Site-wide: 2
    • In infectious diseases: 1
  • Year to date:
    • Site-wide: 7
  • Since beginning of last month:
    • Site-wide: 23

Correlation of SARS-CoV-2 Breakthrough Infections to Time-from-vaccine; Preliminary Study

epidemiology more details view paper
  • Downloaded 125,365 times
  • Download rankings, all-time:
    • Site-wide: 54
    • In epidemiology: 15
  • Year to date:
    • Site-wide: 460
  • Since beginning of last month:
    • Site-wide: 643

Decreased SARS-CoV-2 viral load following vaccination

infectious diseases more details view paper
  • Downloaded 94,110 times
  • Download rankings, all-time:
    • Site-wide: 88
    • In infectious diseases: 31
  • Year to date:
    • Site-wide: 706
  • Since beginning of last month:
    • Site-wide: 971

The effectiveness of the first dose of BNT162 b 2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization: real-world evidence

infectious diseases more details view paper
  • Downloaded 46,094 times
  • Download rankings, all-time:
    • Site-wide: 207
    • In infectious diseases: 78
  • Year to date:
    • Site-wide: 6,762
  • Since beginning of last month:
    • Site-wide: 6,350

Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two Doses and Three doses of the BNT162b2 Vaccine

infectious diseases more details view paper
  • Downloaded 23,970 times
  • Download rankings, all-time:
    • Site-wide: 460
    • In infectious diseases: 179
  • Year to date:
    • Site-wide: 498
  • Since beginning of last month:
    • Site-wide: 3,417

Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine

infectious diseases more details view paper
  • Downloaded 14,405 times
  • Download rankings, all-time:
    • Site-wide: 844
    • In infectious diseases: 291
  • Year to date:
    • Site-wide: 2,238
  • Since beginning of last month:
    • Site-wide: 5,578

Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities at daily resolution

infectious diseases more details view paper
  • Downloaded 12,848 times
  • Download rankings, all-time:
    • Site-wide: 988
    • In infectious diseases: 322
  • Year to date:
    • Site-wide: 4,026
  • Since beginning of last month:
    • Site-wide: 12,372

SARS-CoV-2 infection risk among unvaccinated is negatively associated with community-level vaccination rates

infectious diseases more details view paper
  • Downloaded 10,347 times
  • Download rankings, all-time:
    • Site-wide: 1,304
    • In infectious diseases: 407
  • Year to date:
    • Site-wide: 6,019
  • Since beginning of last month:
    • Site-wide: 12,018

Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel

infectious diseases more details view paper
  • Downloaded 10,217 times
  • Download rankings, all-time:
    • Site-wide: 1,317
    • In infectious diseases: 416
  • Year to date:
    • Site-wide: 2,251
  • Since beginning of last month:
    • Site-wide: 2,762

Relative Effectiveness of Four Doses Compared to Three Dose of the BNT162b2 Vaccine in Israel

public and global health more details view paper
  • Downloaded 5,559 times
  • Download rankings, all-time:
    • Site-wide: 2,958
    • In public and global health: 118
  • Year to date:
    • Site-wide: 282
  • Since beginning of last month:
    • Site-wide: 2,925

A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary report

infectious diseases more details view paper
  • Downloaded 4,501 times
  • Download rankings, all-time:
    • Site-wide: 3,919
    • In infectious diseases: 875
  • Year to date:
    • Site-wide: 2,551
  • Since beginning of last month:
    • Site-wide: 30,106

Waning of SARS-CoV-2 booster viral-load reduction effectiveness

infectious diseases more details view paper
  • Downloaded 4,104 times
  • Download rankings, all-time:
    • Site-wide: 4,483
    • In infectious diseases: 949
  • Year to date:
    • Site-wide: 657
  • Since beginning of last month:
    • Site-wide: 56,030

Association of COVID-19 RT-qPCR test false-negative rate with patient age, sex and time since diagnosis

infectious diseases more details view paper
  • Downloaded 2,844 times
  • Download rankings, all-time:
    • Site-wide: 7,641
    • In infectious diseases: 1,346
  • Year to date:
    • Site-wide: 38,739
  • Since beginning of last month:
    • Site-wide: 82,477

Self-reported and physiological reactions to the third BNT162b2 mRNA COVID-19 (booster) vaccine dose

infectious diseases more details view paper
  • Downloaded 2,555 times
  • Download rankings, all-time:
    • Site-wide: 8,974
    • In infectious diseases: 1,529
  • Year to date:
    • Site-wide: 3,700
  • Since beginning of last month:
    • Site-wide: 25,238

Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents

epidemiology more details view paper
  • Downloaded 2,239 times
  • Download rankings, all-time:
    • Site-wide: 10,962
    • In epidemiology: 880
  • Year to date:
    • Site-wide: 980
  • Since beginning of last month:
    • Site-wide: 23,610

Waning Effectiveness of the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine

public and global health more details view paper
  • Downloaded 2,125 times
  • Download rankings, all-time:
    • Site-wide: 11,879
    • In public and global health: 309
  • Year to date:
    • Site-wide: 1,072
  • Since beginning of last month:
    • Site-wide: 86,028

Naturally-acquired Immunity Dynamics against SARS-CoV-2 in Children and Adolescents

public and global health more details view paper
  • Downloaded 1,850 times
  • Download rankings, all-time:
    • Site-wide: 14,623
    • In public and global health: 369
  • Year to date:
    • Site-wide: 1,304
  • Since beginning of last month:
    • Site-wide: 32,507

Survey of Behaviour Attitudes Towards Preventive Measures Following COVID-19 Vaccination

health policy more details view paper
  • Downloaded 1,296 times
  • Download rankings, all-time:
    • Site-wide: 25,628
    • In health policy: 81
  • Year to date:
    • Site-wide: 14,507
  • Since beginning of last month:
    • Site-wide: 83,500

BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure; Analysis of Household Members of COVID-19 Patients

infectious diseases more details view paper
  • Downloaded 1,200 times
  • Download rankings, all-time:
    • Site-wide: 28,888
    • In infectious diseases: 2,742
  • Year to date:
    • Site-wide: 54,690
  • Since beginning of last month:
    • Site-wide: 97,203

Kinetics of SARS-CoV-2 anti-s IgG after BNT162b2 vaccination

infectious diseases more details view paper
  • Downloaded 1,186 times
  • Download rankings, all-time:
    • Site-wide: 29,457
    • In infectious diseases: 2,768
  • Year to date:
    • Site-wide: 51,857
  • Since beginning of last month:
    • Site-wide: 174,745

Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine

infectious diseases more details view paper
  • Downloaded 821 times
  • Download rankings, all-time:
    • Site-wide: 51,818
    • In infectious diseases: 4,043
  • Year to date:
    • Site-wide: 4,655
  • Since beginning of last month:
    • Site-wide: 15,489

Trends in clinical characteristics and associations of severe non-respiratory events related to SARS-CoV-2

public and global health more details view paper
  • Downloaded 484 times
  • Download rankings, all-time:
    • Site-wide: 103,789
    • In public and global health: 1,547
  • Year to date:
    • Site-wide: 46,860
  • Since beginning of last month:
    • Site-wide: 153,074

A Multilayer Model for Early Detection of COVID-19

infectious diseases more details view paper
  • Downloaded 420 times
  • Download rankings, all-time:
    • Site-wide: 119,191
    • In infectious diseases: 5,855
  • Year to date:
    • Site-wide: 53,101
  • Since beginning of last month:
    • Site-wide: 174,814

Immunosuppression as a hub for SARS-CoV-2 mutational drift

epidemiology more details view paper
  • Downloaded 294 times
  • Download rankings, all-time:
    • Site-wide: 156,082
    • In epidemiology: 6,267
  • Year to date:
    • Site-wide: 25,405
  • Since beginning of last month:
    • Site-wide: 159,623

PanLingua

News